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Abstract: Ultrasound (US)-guided diffuse optical tomography (DOT) has demonstrated poten-
tial value for breast cancer diagnosis and treatment response assessment. However, in clinical
use, the chest wall, poor probe-tissue contact, and tissue heterogeneity can all cause image
artifacts. These image artifacts, appearing commonly as hot spots in the non-lesion regions
(edge artifacts), can decrease the reconstruction accuracy and cause misinterpretation of lesion
images. Here we introduce an iterative, connected component analysis-based image artifact
reduction algorithm. A convolutional neural network (CNN) is used to segment co-registered US
images to extract the lesion location and size to guide the artifact reduction. We demonstrate
its performance using Monte Carlo simulations on VICTRE digital breast phantoms and breast
patient images. In simulated tissue mismatch models, this algorithm successfully reduces edge
artifacts without significantly changing the reconstructed target absorption coefficients. With
clinical data it improves the optical contrast between malignant and benign groups, from 1.55
without artifact reduction to 1.91 with artifact reduction. The proposed algorithm has a broad
range of applications in other modality-guided DOT imaging.
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Near-infrared diffuse optical tomography (DOT) has demonstrated its great potential in breast
cancer diagnosis and treatment response assessment [1–6]. However, due to the intense light
scattering, DOT reconstruction is ill-posed and ill-conditioned. To improve DOT reconstruction,
other imaging modalities, such as magnetic resonance imaging (MRI) [2,7], X-ray CT or
mammography [8,9], and ultrasound (US) [10–16], have been employed. These modalities
provide prior information to DOT imaging reconstruction algorithms to improve the reconstruction
accuracy. We have developed a US-guided DOT technique for diagnosing and characterizing
US-visible breast lesions, with the goal of reducing benign breast biopsies. For US-guided DOT
to be successful, a high optical contrast between malignant and benign breast lesions is crucial.
In clinical studies, the measured diffuse reflectance from the lesion side breast is typically
normalized to the contralateral normal breast (the reference side) to produce perturbation for
imaging reconstruction [17]. However, perturbation is sensitive to probe positions due to tissue
heterogeneity differences (tissue compositions, and chest wall positions) underneath the probe,
and to poor probe-tissue contact, which can generate image artifacts, appearing commonly as hot
spots in the non-lesion regions (edge artifacts). Reducing these artifacts can more accurately
quantify breast lesions and improve diagnosis. Our group has previously reported on the effects
of chest wall mismatch and optode-tissue coupling mismatch and their correction [17–20]. The
correction approaches are targeted at a single error source. Elsewhere in the literature, optical
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properties and optode-tissue coupling coefficients are optimized simultaneously to compensate
for optode coupling errors [21–24]. This compensation method assumes a constant coupling
coefficient for each optode among all measurements involving that optode. Hence. it may not be
applicable to reducing image artifacts caused by a larger scale tissue component, such as the
chest wall or tissue heterogeneity. Based on the assumption that absorption maps of different
wavelengths are similar, Uddin et al. proposed a correction algorithm to remove measurements
that have large model errors [25]. However, by reducing the number of measurements, this
method may lose information. Thus, a correction algorithm is needed that can deal with multiple
error sources without reducing useful measurement information. Connected component analysis,
a method for detecting connected regions in binary images, has been applied in medical imaging
segmentation [26,27], and we adopt it here to remove edge artifacts in DOT images.
By modeling breast tissue as a random matrix with uniformly distributed entries, Ntziachristos
et al. showed that tissue heterogeneity can cause image artifacts and decrease lesion reconstruction
accuracy [28]. A more realistic heterogeneous tissue model could better demonstrate tissue
heterogeneity caused image artifacts and guide the development of correction algorithms. Loue et
al. developed anatomically realistic numerical breast phantoms from clinical contrast-enhanced
MRI data [29]. Deng et al. extracted realistic digital breast phantoms from dual-energy X-ray
mammographic imaging of human breasts and used them in DOT in-silico tests [30,31]. The
numbers of these digital phantoms are limited because the limited availability of real patient
measurements, and they cannot be customized to represent various types of breasts. Recently,
the FDA has released an open-source software model – the VICTRE Breast Phantom [32]. The
software can flexibly customize digital breast phantoms to resemble human breasts with different
sizes, shapes, densities, and so on. It has been applied to X-ray imaging and photoacoustic
tomography [32–35]. Here, we will use VICTRE Breast Phantom to create image edge artifacts
arising from tissue background mismatch.
In this study, we propose a fully automated, connected components analysis-based algorithm
to reduce edge artifacts. We adopt VICTRE breast phantoms in DOT for the first time to account
for tissue heterogeneity, and we demonstrate the effectiveness of the artifact reduction algorithm.
The algorithm, combined with an interactive convolutional neural network (CNN) that segments
coregistered US images to extract the lesions, is also evaluated with clinical data that includes 14
patients of seven benign and seven malignant lesions.
2. Methods
2.1. US-guided DOT system
Our compact, frequency domain US-guided DOT system was previously described in Ref. [15].
Briefly, four laser diodes, with wavelengths of 740, 780, 808, and 830 nm, are modulated at
140 MHz and sequentially delivered light to nine source positions on the probe. The light
reflected from the tissue is detected by ten parallel photomultiplier tube (PMT) detectors. The
source-detector separations range from 0.9 cm to 7.4 cm, and the arrangements are shown in
Fig. 1. The detected signals are demodulated to 20 kHz by a local oscillator of 140.02 MHz and
then digitized and sampled by two 8-channel A/D data acquisition cards. A US probe in the
middle of the DOT probe provides the lesion shape and location.
2.2. Monte Carlo simulation on VICTRE breast phantom
The VICTRE software was used to generate digital breast phantoms with a voxel size of 0.5
× 0.5× 0.5 mm3. The phantoms measured 14 cm in the x- and y-direction and 8 cm in the
z-direction. Breast phantoms with different densities were created by varying the fat fraction from
20% to 80%, in 20% steps. The breast phantoms consisted of five tissue types – fat, glandular,
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Fig. 1. US-guided DOT probe geometry.
skin, muscle (chest wall), and blood vessels, and cross-sections of representative digital breasts
are shown in Fig. 2.
Fig. 2. Three-dimensional visualizations (top row) and cross-sections (bottom row) of
selected digital breast phantoms with different densities.
The digital phantoms were numerically compressed uniformly to 5 cm in the z-direction to
simulate compression by our hand-held reflection-mode DOT probe. After compression, the
volume was down-sampled using nearest neighbor interpolation to achieve a voxel size of 2.5 ×
2.5× 2.5 mm3 for Monte Carlo simulation [36]. Figure 3 illustrates the pre-processing of the
digital phantoms.
Fig. 3. Pre-processing of digital breast phantoms for Monte Carlo simulation. The digital
breast has a fat fraction of 40%.
The values of the optical absorption coefficient (µa) and reduced scattering coefficient (µs’)
assigned to each tissue component were calculated and are shown in Table 1. Spherical lesions
of both high contrast (with oxygenated hemoglobin (HbO) and de-oxygenated hemoglobin (HbR)
equal to the average values from the malignant group [15]) and low contrast (with HbO and HbR
equal to the average values from the benign group [15]) were inserted in the lesion side breast. To
calculate the normalized perturbation, diffuse reflectance was measured from both the lesion-side
and reference-side breasts. The volume surrounding the compressed digital breasts was filled
with air, which leaves space for phantom translation and rotation, achieving a total volume of 63
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× 63 × 20 grids. One hundred million photons were used for simulation, and the time required
to generate one set of forward data (9 × 10 measurements) was less than two minutes using
GPU-accelerated code [36] on a NVIDIA Quadro P2000. To better simulate tissue heterogeneity
mismatch due to probe positioning in clinical settings, tissue components of the reference side
and the lesion side were assumed to be the same, but the reference side was translated by 0.5 cm
in the+ x, -x, +y, or -y-direction, or was rotated 10° around the x, y, or z-axis, achieving a total
of seven background tissue mismatch conditions. For each target contrast (high contrast with
target tHb= 98.5 µM, and low contrast with target tHb= 63.2 µM), we tested three target radii
(0.5, 0.75, and 1 cm), three target depths (1.5, 2.0, and 2.5 cm), four breast densities, and seven
different background mismatch conditions, resulting in a total of 252 cases.
























Fat [30,37] 13.8 4.8 18.7 0.028 0.036 0.037 0.041 7.96 7.56 7.31 7.13
Glandular
tissue [30,37]
19.0 6.5 25.4 0.036 0.047 0.048 0.053 9.00 8.56 8.28 8.07
Skin [38] 0.45 0.44 0.43 0.40 17.23 17.03 16.90 16.80
Muscle [39] 0.15 0.17 0.18 0.12 9.98 9.16 8.65 8.28
Blood vessel
[37]
204.8 5.2 210.0 3.47 5.39 6.39 7.25 0.00 0.00 0.00 0.00
Low contrast
lesion [15,37]
38.0 25.2 63.2 0.10 0.12 0.12 0.13 11.85 11.28 10.92 10.65
High contrast
lesion [15,37]
65.0 33.5 98.5 0.15 0.19 0.18 0.20 11.85 11.28 10.92 10.65
2.3. Optode coupling mismatch and chest wall mismatch model
To further demonstrate the generalizability of the edge artifact reduction algorithm, an optode
coupling and a chest wall mismatch model were also used to generate edge artifacts. As shown in
Fig. 4(a), to create optode coupling mismatch, a homogeneous (fat) digital breast was used to
minimize the effects of tissue heterogeneity and focus on the effects of optode coupling errors.
We assumed that one side of the breast was in good contact, but one detector located at (−4 cm,
0, 0) on the other side had an airgap [20]. To simulate breasts with chest walls, two-layer digital
breasts were used, with the top layer consisting of fat and the bottom layer muscle. The chest
wall was at 2.5 cm deep. To create chest wall angle mismatch, the chest wall on one side was
tilted 10° and the chest wall on the other side was kept flat (Fig. 4(b)). High contrast targets were
inserted in the lesion-side breasts. The target had a 0.5 cm radius and a 1 cm depth. The optical
properties assigned to the fat and muscle can be found in Table 1.
2.4. Clinical data and ultrasound segmentation using CNN
Patient data from seven benign and seven malignant cases were used to evaluate the artifact
reduction algorithm. The study protocol was approved by the local Institutional Review Board
and was compliant with the Health Insurance Portability and Accountability Act. The data used
in this manuscript were deidentified. This group of fourteen patients had an average age of 47.5
years (±18.2 years). The means and standard deviations of the lesion radii in the x-direction,
the lesion radii in the z-direction, and the depths measured with the US segmentation method
described below are 0.76± 0.39 cm, 0.51± 0.19 cm, and 1.32± 0.50 cm, respectively.
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Fig. 4. Illustration of (a) optode coupling mismatch and (b) chest wall mismatch model.
We used a semi-automated CNN to segment breast lesions from the coregistered US images of
clinical data and guide the edge artifact reduction. This CNN was developed by Maninis et al.
by fine-tuning a CNN model pre-trained on ImageNet, with PASCAL, a well-known standard
dataset [40], and it has been successfully applied to breast lesion segmentation in US images to
improve DOT reconstruction [16]. After we selected four boundary markers, two in the lateral
dimension and two in the depth dimension, the CNN automatically segmented the 2D shape of
the lesion. After the lesion was extracted, its centroid in the x-z plane (xc, zc) was calculated.
Because our US transducer was located in the middle of our DOT probe, we assumed the lesion
center to be (xc, 0, zc). We then approximated the lesion shape as an ellipsoid centered at (xc,
0, zc), with axes in the x-, y-, and z-directions equal to the maximum dimensions in the x-, x-
(approximately as y-), and z-directions of the segmented lesion. Then we used an ellipsoid with
the same center and long and short axes of three times as long to define the outer boundary of
the lesion area. Outside the larger ellipsoid, we can confidently assume any hot spots were edge
artifacts. The larger ellipsoid will be used to determine the max(δµa,tar) in Algorithm 1 and
quantify the effectiveness of the algorithm applied on background tissue mismatched simulations.
The algorithm defined a larger boundary than that of the US-identified lesion for four reasons: 1)
DOT has much lower spatial resolution than US; 2) Edges of the breast lesions seen by US are
often not clear due to poor contrast; 3) Co-registered US B-Scan images provide lesion size in one
spatial dimension, and the size in another dimension is based on an estimate that the breast lesion
in general is ellipsoid; and 4) Lesion US images are based on mechanical contrast and optical
distribution is based on absorption contrast. Thus, it is not always possible to co-locate both
US and optical images. As an example, in Fig. 5(b), the red shaded area is the CNN segmented
lesion, with green crosses indicating four markers selected by hand. A yellow diamond marks the
centroid of the lesion, the blue line shows the approximated lesion shape, and the white dashed
line marks the boundary of the lesion area.
2.5. Image reconstruction
The normalized perturbation Usc was used to reconstruct the unknown optical properties, and it
is calculated as the frequency domain measurements from the lesion-side breast normalized to





where Ul(i) and Ur(i) are the lesion-side and the reference-side measurements, respectively. A
conjugate gradient algorithm and a dual mesh scheme were employed to solve the DOT inverse
problem, which was linearized as the following regularized optimization problem [41]:
f (x) = arg minδµa
(︃
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Fig. 5. Illustration of US segmentation. (a) Coregistered US lesion image. (b) US
segmentation and information extraction. The red shaded area is the lesion, segmented using
CNN. Green crosses are four markers selected by hand. The lesion’s centroid is marked
with a yellow diamond, the blue line shows the approximate lesion shape, and the whited
dashed line marks the boundary of the lesion area, an ellipsoid with the same center but
three times as large as the lesion.
Here, δµa represents the unknown changes in µa compared to the reference side, and W is
a sensitivity matrix of the semi-infinite homogenous medium. In both simulation and patient
experiments, W was calculated using Born approximation based on the optical properties µa0
and µs0’, obtained from the reference side measurements via linear fitting of the log amplitude
vs. source-detector distance and phase vs. source-detector distance [42]. λ is a regularization
parameter. The µa map on the lesion side was obtained by adding the reconstructed δµa to the
background absorption coefficient, µa0. A total of seven layers in the depth- or z-direction are
reconstructed, with a 0.5-cm spacing between adjacent layers. For better visualization, we show
only the top layer of the reconstructed image containing the target.
2.6. Edge artifact reduction and quantification
When there are edge artifacts outside the lesion area, the algorithm removes the portion of the
perturbation that contributes to the artifacts (Usc,artifacts) from Usc by zeroing out the absorption
coefficient of the artifacts (δµa,artifacts) in the original reconstructed absorption map, as formulated
in Eq. (3).
Usc,new = Usc − Usc,artifacts = Usc − Wδµa,artifacts. (3)
Thus, the algorithm finds all the connected components in the reconstructed δµa maps and
iteratively removes all other components on the edge (artifacts), until there is only one component
(the lesion) left, whose centroid is closest to the ultrasound-identified lesion centroid. For
details, see Algorithm 1 and Fig. 6. After edge artifacts were reduced at each wavelength, the
reconstructed absorption maps of all four wavelengths were linearly weighted using extinction
coefficients obtained from Ref. [39] to obtain the total hemoglobin (tHb) distribution. The
Wilcoxon rank sum test, a non-parametric test which is appropriate when comparing two small
groups of samples without making a normal distribution assumption, was used to evaluate the
statistical significance. A p-value of less than 0.05 was considered statistically significant. All
image reconstruction, artifact reduction, and statistical tests were conducted using MATLAB.
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Fig. 6. Flow chart for the edge artifact reduction algorithm.
3. Results
3.1. Simulation results
3.1.1. Background tissue mismatch
Figure 7 illustrates the edge artifact reduction process at 780 nm applied to a high contrast target
with a 1 cm radius at a 2 cm depth. In this example, the algorithm identified two connected
components in the original reconstructed image, and successfully reduced the one edge artifact
on the top right.
Fig. 7. Illustration of the edge artifact reduction process (780 nm). The breast phantom had
a fat fraction of 40%, and the reference side was translated 0.5 cm in the -x direction. The
high contrast target, located at depth of 2 cm, had a radius of 1 cm.
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Figure 8 shows four examples of reconstructed tHb maps from VICTRE digital breast
simulations, before and after artifact reduction. For all breast densities, when the same
background tissue is used for the reference side and the lesion side, tissue heterogeneity has less
impact on the reconstructed images (Fig. 8(b)). On the other hand, when there is a mismatch in
the background tissue between the two sides, it can cause significant image artifacts, appearing
as hot spots on the edges of the fine-mesh area of the dual-mesh scheme (Fig. 8(c), enclosed
in black circles). The artifact reduction algorithm successfully reduces these edge artifacts and
restores the reconstructed target image to be almost comparable to the images without background
mismatch. As shown in Table 2, after the artifact reduction algorithm is applied, the maximum
reconstructed tHb for all four examples slightly changes (absolute changes < 3%) from its value
before artifact reduction.
Table 2. Maximum reconstructed tHb, with and without background tissue mismatch








20% 83.8 85.7 87.7 +2.36%
40% 90.8 89.3 87.2 −2.41%
60% 83.4 81.5 82.5 +1.25%
80% 94.6 74.1 75.6 +2.07%
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Fig. 8. Total hemoglobin maps of four digital breasts with different densities. (a) Ground
truth. (b) Reconstructed tHb maps without background mismatch. (c) and (d), Reconstructed
tHb maps with background mismatch, before and after artifact reduction. The target
tHb= 98.5 µM, radius= 0.75 cm, and depth= 2 cm. Each image slice measures 8 cm by 8 cm
and remains the same for subsequent tHb maps. Image artifacts that have δµa larger than
0.5max(δµa,tar) for at least one wavelength are enclosed in black ellipses.
To better demonstrate the performance of the artifact reduction algorithm, Fig. 9 shows box
plots of the maximum reconstructed tHb inside and outside the target area for high contrast
targets of different sizes and depths, before and after applying the algorithm. As described in
Section 2.2, each target comprised four breast densities and seven different background mismatch
conditions, making a set of 28 images in all. Each box plot provides statistical information about
the images with edge artifacts among this set of 28 images. The target area, defined as a sphere
centered on the target, has a radius three times as large as the target’s radius. For all images with
edge artifacts, the maximum reconstructed tHb inside the target area is in general lower and more
spread out for smaller and deeper targets, and the averaged maximum reconstructed tHb outside
the target area is roughly the same for all target sizes and depths. The Wilcoxon rank sum test
showed that the artifact reduction algorithm successfully reduced the image artifacts outside the
target area for all cases (p< 0.05), except for targets with a 0.5-cm radius and a 2.5-cm depth.
The maximum reconstructed target tHb was not significantly changed for all cases (p> 0.05).
Table 3 gives the numbers of images with edge artifacts for each target radius and depth, the
ratio of the maximum reconstructed tHb inside the target area over that outside the target area
of these images, and statistical test results for both high and low contrast targets. For smaller
and deeper targets, more images have edge artifacts, and the ratios of maximum reconstructed
tHb inside the target area over that outside the target area are in general smaller, indicating
that smaller and deeper targets are more likely to be misinterpreted due to background tissue
mismatch. For all cases, the artifact reduction algorithm improves this ratio. The statistical
test for low contrast targets had the same conclusions as the high contrast targets: the artifact
reduction algorithm significantly reduced the image artifacts outside the target area for all cases
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Fig. 9. Box plots of maximum reconstructed tHb inside and outside the target area, from
simulations of high contrast targets with different radii and depths, four breast densities, and
seven background tissue mismatch conditions, before and after artifact reduction.
except for targets with a 0.5-cm radius and a 2.5-cm depth, and it did not significantly change the
maximum reconstructed target tHb for all cases.
3.1.2. Optode coupling and chest wall mismatch
Figure 10 shows reconstructed images with optode coupling mismatch and chest wall mismatch,
before and after artifact reduction. In (a) top, one detector on the reference side has an air gap,
creating an edge artifact on the left, close to the detector with the air gap. In (a) bottom, one
detector on the target side has an air gap, creating two hot spots on the left, close to the two
detectors close to the boundary. In (b), the chest wall on the target side or the reference side is
tilted 10°, and both conditions induce edge artifacts on the reconstructed image. The algorithm
successfully reduced the edge artifacts in all cases, without significantly changing the target tHb
(absolute change < 4%). The restored images are comparable to the results using the optode
coupling correction [20], which removes measurements corresponding to the optode(s) with
large modeling errors, or to the chest wall correction method [17], which scales the original
perturbation using simulations based on the chest wall geometry and the fitted optical properties
of the tissue and the chest wall.
3.2. Clinical examples
Figure 11 shows representative tHb maps from two patients, one with a benign lesion (a) and
another with a malignant tumor (b), before and after the artifact reduction algorithm was applied.
In Fig. 11(a) left, the coregistered US image of a 40-year-old patient with a benign fibroadenoma,
the 1.1-cm deep lesion measures 1.5 cm and 0.7 cm in the x- and z-directions, respectively.
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Table 3. Number of images with artifacts (at least one wavelength), ratio of maximum
reconstructed tHb inside the target area over that outside the target area, and statistical test results








with artifacts / total
number of images
Target maximum tHb / artifact
maximum tHb (mean± std, in µM)
p-value: before vs.
after
Before After Target Artifact
High
contrast
0.5 1.5 26 / 28 0.907 ± 0.253 1.204 ± 0.338 0.721 < 0.001
0.5 2 27 / 28 0.729 ± 0.174 0.838 ± 0.188 0.876 0.016
0.5 2.5 27 / 28 0.763 ± 0.218 0.823 ± 0.213 0.736 0.141
0.75 1.5 14 / 28 1.658 ± 0.305 2.130 ± 0.238 0.505 0.002
0.75 2 24 / 28 1.360 ± 0.404 1.799 ± 0.513 0.477 < 0.001
0.75 2.5 26 / 28 1.056 ± 0.245 1.259 ± 0.338 0.735 0.005
1 1.5 11 / 28 1.670 ± 0.276 2.071 ± 0.280 0.511 0.003
1 2 13 / 28 1.835 ± 0.324 2.256 ± 0.308 0.837 0.016
1 2.5 24 / 28 1.529 ± 0.431 1.738 ± 0.427 0.439 0.007
Low
contrast
0.5 1.5 26 / 28 0.780 ± 0.207 1.005 ± 0.286 0.641 < 0.001
0.5 2 26 / 28 0.681 ± 0.157 0.806 ± 0.184 0.749 0.008
0.5 2.5 27 / 28 0.730 ± 0.196 0.785 ± 0.186 0.829 0.210
0.75 1.5 23 / 28 1.462 ± 0.321 1.872 ± 0.346 0.429 < 0.001
0.75 2 25 / 28 1.082 ± 0.276 1.376 ± 0.428 0.388 < 0.001
0.75 2.5 25 / 28 0.966 ± 0.168 1.076 ± 0.230 0.308 0.033
1 1.5 17 / 28 1.559 ± 0.272 1.965 ± 0.235 0.389 < 0.001
1 2 23 / 28 1.473 ± 0.261 1.908 ± 0.323 0.410 < 0.001
1 2.5 25 / 28 1.228 ± 0.246 1.399 ± 0.326 0.244 0.002
The proposed algorithm successfully reduced two hot spots on the edge, and the resulting tHb
map correctly shows the lesion in the corresponding region in the US image. The maximum
reconstructed tHb decreased by 45.1%. In (b), a 51-year-old patient with an invasive mammary
ductal carcinoma, the lesion has a depth of 1.2 cm, and it measures 1.2 cm and 0.8 cm in the
x- and z-directions, respectively. The reconstructed hemoglobin map has one hot spot outside
the lesion area. After the algorithm has processed the data, the edge artifacts outside the tumor
region shown in the US image are reduced, and the maximum reconstructed tHb has decreased
by 14.9%.
Figure 12 shows box plots of the maximum reconstructed tHb for seven benign and seven
malignant cases, before and after artifact reduction. The algorithm decreased the maximum
reconstructed tHb for both malignant and benign lesions. However, the ratio of the averaged
maximum reconstructed tHb of the malignant lesions (n=7) to that of benign lesions (n=7) was
improved (from1.55 to 1.91), indicating an increase in optical contrast distinguishing between
malignant and benign lesions. The Wilcoxon rank sum test showed that after artifact reduction,
the malignant group and benign group were significantly different in terms of the maximum
reconstructed tHb (p< 0.005), while before artifact reduction they are not (p> 0.05).
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Fig. 10. (a) Ground truth tHb maps and reconstructed tHb maps with optode coupling
mismatch, before and after artifact reduction and after optode coupling correction [20]. One
detector (−4 cm, 0, 0) had an airgap. (b) Ground truth tHb maps and reconstructed tHb maps
with chest wall mismatch, before and after artifact reduction, and after chest wall correction
[17]. The chest wall has a depth of 2.5 cm and is tilted 10°. The high contrast lesion has a
radius of 0.5 cm and a depth of 1 cm.
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Fig. 11. Coregistered US images, original reconstructed tHb maps, and tHb maps after
applying the artifact reduction algorithm for (a) a benign fibroadenoma and (b) a malignant
tumor. Color bars indicate the tHb level, in units of µM. Image artifacts that have δµa larger
than 0.5max(δµa,tar) for at least one wavelength are enclosed in black ellipses.
Fig. 12. Box plots of maximum reconstructed tHb for seven benign and seven malignant
cases, before and after artifact reduction.
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4. Discussion and summary
In this work, we introduced an iterative edge artifact reduction algorithm based on connected
component analysis. The proposed artifact-reduction algorithm uses the structural prior and
modifies the data to produce images that agree with the structural prior. Unlike previous
correction algorithms that deal with optode coupling or the chest wall [17, –24], it does not make
assumptions about the sources that caused the image artifacts. The algorithm successfully reduced
hot spots appearing in non-lesion regions (edge artifacts), which, in patient experiments, can arise
from mismatches of the chest wall position underneath the breast tissue [18], poor probe-tissue
contact [20], and tissue heterogeneity. It may also reduce the high optical contrast at the edges
of healthy tissue, such as dense glands, biopsy sites, or scar due to lumpectomy, improving the
lesion-to-background tissue contrast for more accurate lesion diagnosis and characterization. We
first demonstrated the performance of the algorithm using Monte Carlo simulations on VICTRE
digital breast phantoms. Realistic and flexible VICTRE breast phantoms of different fat fractions
were used in DOT simulations for the first time to account for tissue heterogeneity. When the
same background tissue was used for the reference side and the lesion side, fewer edge artifacts
were observed in the reconstructed images, because our “normalized perturbation” approach
reduced the impact of tissue heterogeneity. However, when there was a tissue mismatch between
the two sides, edge artifacts were often generated, but they were successfully reduced by our
algorithm. The proposed algorithm can also reduce edge artifacts caused by optode coupling
mismatch or chest wall mismatch, and it produces images comparable to those using the previous
correction algorithms developed by our group that deals with a single mismatch error [17,20].
Compared to the optode coupling correction method in [20], the proposed algorithm does not
decrease the number of the measurements. Compared to the chest well correction method in
[17], there is no need for accurate estimation of the chest wall geometry, time-consuming fitting
of the optical properties of breast tissue and the chest wall, or additional forward simulations.
We also tested the algorithm using breast patient data with image artifacts outside the lesion
areas. Interestingly, compared to all the patient data we had, we noticed from US B-scan images
that this group of patients with image artifacts was more likely to have dense breasts. Denser
breasts make it harder for the DOT probe to make good contact and harder to match the positions
of the two sides. A CNN-based US segmentation algorithm was incorporated to extract lesion
size and location information and guide the artifact reduction. Other segmentation approaches,
such as a clustering-based approach [43] or a watershed-based approach [44], can also be used to
obtain lesion information from breast lesion US images. Combined with the US segmentation
algorithm, this edge artifact reduction algorithm showed success in removing edge artifacts and
improving tHb contrast between malignant and benign lesions for clinical data. Although the
edge artifacts in this study were generated by probe positioning differences between the reference
and lesion side measurements, unwanted artifacts outside the target region can also occur if
optode coupling errors exist in a single DOT measurement [21–24]. Our approach may also be
applicable to such cases.
Our studies have several limitations. First, although different densities of digital breast
phantoms were included in this study, breast types were still limited in terms of size, shape, chest
wall depth and angle, and many other variables. Second, due to modest available computational
power, the Monte Carlo grids used in this study were relatively large (2.5 × 2.5× 2.5 mm3), which
reduced the level of detail in the digital breasts and decreased the reality of the simulations. For
example, after numerically compressing and down-sampling the digital breast, the skin layer, with
only a 1 mm thickness, was no longer present on the top plane of the breast. In the Monte Carlo
simulation, photon noise also increased inaccuracy in the forward calculation. More accurate
and realistic simulations can be achieved with greater computational resources. Further, we
assumed the background tissue had the same component distribution on the lesion side and the
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reference side, and that the mismatch was generated from probe positioning. In patients, the
tissue components of the two side breasts can be different.
The algorithm demonstrated its effectiveness in reducing artifacts on the edges. It slightly
changes the reconstructed lesion µa and does not alter the lesion position or shape. When a
strong tissue background mismatch causes a large shift in the target position or causes the target
and the artifact to merge into one component (conditions that are more frequently observed with
smaller and deeper lesions), this algorithm does not work well. Also, in rare cases, there may be
multiple lesions within the field of view of our DOT probe, in which case co-registered US can
identify the number of lesions and the lesion locations. The proposed algorithm can be modified
accordingly to keep the number of desired connected components as the number of the lesions.
In addition, this algorithm is not applicable to large lesions for which the defined lesion area
(three times the lesion size) covers the whole reconstructed image volume. Also, cancers larger
than 4 to 5 cm may contain necrotic cores due to the aggressive growth of the cancer cells. In
comparison with the tHb map of a single-connected blob, the tHb value of this necrotic core is
lower than the peripheral tHb value, and the algorithm does not apply to such cases. However, as
shown in Fig. 10 and Table 3, the ratios of the averaged reconstructed µa inside the target area
over that outside the target area are larger for larger targets, indicating they are less influenced
by background tissue mismatch. This algorithm also increases the reconstruction time, and the
additional time mainly comes from the additional reconstruction process in each iteration. The
median number of iterations needed to remove the image artifacts was two, adding approximately
twice the original reconstruction time.
In summary, to reduce edge artifacts in US-DOT, we proposed an edge artifact reduction
algorithm based on connected component analysis and combined with a US-segmentation CNN.
We demonstrated its effectiveness using simulations on VICTRE digital breast phantoms and
clinical data. Our approaches have significant implications for reducing image edge artifacts in
other modality-guided DOT imaging in general, where the lesion count, size, and position can be
reliably obtained through other modalities.
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